Chemotherapy prescribing habits for stage 3 colon cancer changed following IDEA study
Hospital Pharmacy Europe
AUGUST 14, 2023
A significant and increasing trend towards the use of a three-month rather than six-month adjuvant chemotherapy regime in stage 3 colon cancer has been observed following publications from the IDEA collaboration abstract. In addition, CAPOX prescribing also significantly increased from 14% to 48% (p <0.001).
Let's personalize your content